From OT Europe

DePuy Synthes announces availability of continuous compression implants for foot, ankle procedures

DePuy Synthes announced the availability of continuous compression implants for healing of reconstructive foot and ankle procedures to health care providers in Europe, the Middle East and Africa.

According to a company press release, the DePuy Synthes Continuous Compression Implants are manufactured with a specific formulation of nitinol that continuously keeps bones compressed together during the healing process. The compression reportedly reduces complication risks and allows patients to return to normal activity quickly. The continuous compression implants come ready to use, sterile and pre-loaded onto an insertion tool.

“DePuy Synthes introduction of Continuous Compression Implants to [Europe, the Middle East and Africa] EMEA-based health care providers is testament to our commitment to deliver value-added innovation and improved access to tools that both simplify procedures and improve patient outcomes,” Virve Sarja, DePuy Synthes Trauma & CMF Lead, EMEA, said in the release. “These implants and single-use instruments have been shown to improve operating theatre efficiencies, reduce costs and help the patient quickly return to their normal daily activities.”

Reference:

www.depuysynthes.com

DePuy Synthes announced the availability of continuous compression implants for healing of reconstructive foot and ankle procedures to health care providers in Europe, the Middle East and Africa.

According to a company press release, the DePuy Synthes Continuous Compression Implants are manufactured with a specific formulation of nitinol that continuously keeps bones compressed together during the healing process. The compression reportedly reduces complication risks and allows patients to return to normal activity quickly. The continuous compression implants come ready to use, sterile and pre-loaded onto an insertion tool.

“DePuy Synthes introduction of Continuous Compression Implants to [Europe, the Middle East and Africa] EMEA-based health care providers is testament to our commitment to deliver value-added innovation and improved access to tools that both simplify procedures and improve patient outcomes,” Virve Sarja, DePuy Synthes Trauma & CMF Lead, EMEA, said in the release. “These implants and single-use instruments have been shown to improve operating theatre efficiencies, reduce costs and help the patient quickly return to their normal daily activities.”

Reference:

www.depuysynthes.com